Abstract: The present disclosure relates to a drainage catheter and methods of use for providing catheterization procedures, such as during a percutaneous nephrostomy. The drainage catheter includes a body including a first tube segment and a second tube segment connected to one another at a curved end portion to form a continuous body structure. An inner surface of the curved end portion includes one or more drainage openings extending therethrough, with an outer surface of the curved end portion free of drainage openings. The openings are in communication with a lumen that extends through the drainage catheter to provide a pathway for removing fluid from the kidney. The drainage catheter is inserted into the kidney via a first insertion site and exits via a second insertion site.

Abstract: Green-emitting phosphors are useful in devices including an LED light source radiationally coupled and/or optically coupled to the phosphors, which are selected from [Ba1-a-bSraCab]x[Mg,Zn]y(UO2)z[P,V]O4)2(x+y+z)/3, where 0?a?1, 0?b?1, 0.75?x?1.25, 0.75?y?1.25, 0.75?z?1.25; and [Ba,Sr,Ca,Mg,Zn]p(UO2)q[P,V]rO(2p+2q+5r)/2, where 2.5?p?3.5, 1.75?q?2.25, 3.5?r?4.5.

Abstract: A phosphor composition includes an activated uranium-based phosphor having formula I or II. The phosphor is doped with Eu3+ [Ba1?a?bSraCab]x[Mg,Zn]y(UO2)z([P,V]O4)2(x+y+z)/3??(I) [Ba1?a?bSraCab]p(UO2)q[P,V]rO(2p+2q+5r)/2??(II) where 0?a?1, 0?b?1, 0.75?x?1.25, 0.75?y?1.25, 0.75?z?1.25, 2.5?p?3.5, 1.75?q?2.25, and 3.5?r?4.5 and formula II excludes the combination where a is 0, b is 0, p is 3.5, q is 1.75, and r is 3.5. Phosphor compositions further including formula VI or other luminescent materials, such as quantum dots, devices and displays are also provided.

Abstract: Green-emitting phosphors are useful in devices including an LED light source radiationally coupled and/or optically coupled to the phosphors, which are selected from [Ba1?a?bSraCab]x[Mg,Zn]y(UO2)z([P,V]O4)2(x+y+z)/3, where 0?a?1, 0?b?1, 0.75?x?1.25, 0.75?y?1.25, 0.75?z?1.25; and [Ba,Sr,Ca,Mg,Zn]p(UO2)q[P,V]rO(2p+2q+5r)/2, where 2.5?p?3.5, 1.75?q?2.25, 3.5?r?4.5.

Abstract: A phosphor composition includes an activated uranium-based phosphor having formula I or II. The phosphor is doped with Eu3+ [Ba1?a?bSraCab]x[Mg,Zn]y(UO2)z([P,V]O4)2(x+y+z)/3??(I) [Ba1?a?bSraCab]p(UO2)q[P,V]rO(2p+2q+5r)/2??(II) where 0?a?1, 0?b?1, 0.75?x?1.25, 0.75?y?1.25, 0.75?z?1.25, 2.5?p?3.5, 1.75?q?2.25, and 3.5?r?4.5 and formula II excludes the combination where a is 0, b is 0, p is 3.5, q is 1.75, and r is 3.5. Phosphor compositions further including formula VI or other luminescent materials, such as quantum dots, devices and displays are also provided.

Abstract: The present techniques relate to various aspects of forming and filling high-aspect ratio trench structures (e.g., trench structures having an aspect ratio of 20 or greater, including aspect ratios in the range of 20:1 up to and including 50:1 or greater) combined with trench opening widths ranging from 0.5 micron to 50 microns. By way of example, patterned substrate described herein includes a substrate, a mask layer deposited on the substrate, and a photoresist layer deposited on the mask layer. The photoresist layer is patterned to form a pattern and the mask layer is etched through the pattern to expose the substrate. The substrate is etched through the pattern to form a structure comprising a plurality of trenches having vertical sidewall. The photoresist layer remains on the mask layer during etching of the substrate.

Abstract: A phosphor composition includes an activated uranium-based phosphor having formula I or II. The phosphor is doped with Eu3+ [Ba1-a-bSraCab]x[Mg,Zn]y(UO2)z([P,V]O4)2(x+y+z)/3??(I) [Ba1-a-bSraCab]p(UO2)q[P,V]rO(2p+2q+5r)/2??(II) where 0?a?1, 0?b?1, 0.75?x?1.25, 0.75?y?1.25, 0.75?z?1.25, 2.5?p?3.5, 1.75?q?2.25, and 3.5?r?4.5 and formula II excludes the combination where a is 0, b is 0, p is 3.5, q is 1.75, and r is 3.5. Phosphor compositions further including formula VI or other luminescent materials, such as quantum dots, devices and displays are also provided.

Abstract: Briefly, in one aspect, the present invention relates to processes for producing a stabilized Mn4+ doped phosphor in solid form and a composition containing such doped phosphor. Such process may include combining a) a solution comprising at least one substance selected from the group consisting of: K2HPO4, an aluminum phosphate, oxalic acid, phosphoric acid, a surfactant, a chelating agent, or a combination thereof, with b) a Mn4+ doped phosphor of formula I in solid form, where formula I may be: Ax [MFy]:Mn4+. The process can further include isolating the stabilized Mn4+ doped phosphor in solid form. In formula I, A may be Li, Na, K, Rb, Cs, or a combination thereof. In formula I, M may be Si, Ge, Sn, Ti, Zr, Al, Ga, In, Sc, Y, La, Nb, Ta, Bi, Gd, or a combination thereof. In formula I, x is the absolute value of the charge of the [MFy] ion and y is 5, 6 or 7.

Abstract: An equatorial anthropic radiation source and a method of making an equatorial anthropic radiation source are described. The radiation source is useful in diagnostic imaging applications in healthcare or other industries (e.g. computerized three-dimensional segmental imaging; Crompton scattering imaging techniques; radiation detector check and calibration, in particular CdZnTe detectors commonly used in medical imaging).

Abstract: Green-emitting phosphors are useful in devices including an LED light source radiationally coupled and/or optically coupled to the phosphors, which are selected from [Ba1?a?bSraCab]x[Mg,Zn]y(UO2)z([P,V]O4)2(x+y+z)/3, where 0?a?1, 0?b?1, 0.75?x?1.25, 0.75?y?1.25, 0.75?z?1.25; and [Ba,Sr,Ca,Mg,Zn]p(UO2)q[P,V]rO(2p+2q+5r)/2, where 2.5?p?3.5, 1.75?q?2.25, 3.5?r?4.5.

Abstract: The present techniques relate to various aspects of forming and filling high-aspect ratio trench structures (e.g., trench structures having an aspect ratio of 20 or greater, including aspect ratios in the range of 20:1 up to and including 50:1 or greater) combined with trench opening widths ranging from 0.5 micron to 50 microns. In one implementation a method to fabricate high-aspect ratio trenches in silicon is provided using a patterned photoresist on evaporated aluminum. In accordance with this approach, a high-aspect ratio trench can be formed having vertical side walls and defect-free trench bottoms. In some instances it may be desirable to fill such high-aspect ratio trench structures with a metal or other substrate to provide certain functionality associated with the fill material. Further processes and structures are related in which such trench structures are filled using a mixture of high-Z nano-particles within an epoxy resin matrix.

Abstract: Briefly, in one aspect, the present invention relates to processes for producing a stabilized Mn4+ doped phosphor in solid form and a composition containing such doped phosphor. Such process may include combining a) a solution comprising at least one substance selected from the group consisting of: K2HPO4, an aluminum phosphate, oxalic acid, phosphoric acid, a surfactant, a chelating agent, or a combination thereof, with b) a Mn4+ doped phosphor of formula I in solid form, where formula I may be: Ax [MFy]:Mn4+. The process can further include isolating the stabilized Mn4+ doped phosphor in solid form. In formula I, A may be Li, Na, K, Rb, Cs, or a combination thereof. In formula I, M may be Si, Ge, Sn, Ti, Zr, Al, Ga, In, Sc, Y, La, Nb, Ta, Bi, Gd, or a combination thereof. In formula I, x is the absolute value of the charge of the [MFy] ion and y is 5, 6 or 7.

Abstract: Briefly, in one aspect, the present invention relates to processes for producing a stabilized Mn4+ doped phosphor in solid form and a composition containing such doped phosphor. Such process may include combining a) a solution comprising at least one substance selected from the group consisting of: K2HPO4, an aluminum phosphate, oxalic acid, phosphoric acid, a surfactant, a chelating agent, or a combination thereof, with b) a Mn4+ doped phosphor of formula I in solid form, where formula I may be: Ax [MFy]:Mn4+. The process can further include isolating the stabilized Mn4+ doped phosphor in solid form. In formula I, A may be Li, Na, K, Rb, Cs, or a combination thereof. In formula I, M may be Si, Ge, Sn, Ti, Zr, Al, Ga, In, Sc, Y, La, Nb, Ta, Bi, Gd, or a combination thereof. In formula I, x is the absolute value of the charge of the [MFy] ion and y is 5, 6 or 7.

Abstract: Devices used to pressurize, depressurize, or otherwise displace fluid are disclosed. The devices may be configured to displace fluid in order to inflate or deflate a medical device, such as a balloon. The devices further include a crank member for providing a mechanical advantage when pressurizing or otherwise displacing fluid.

Abstract: A process for coating a phosphor of formula I: Ax[MFy]:Mn4+ includes combining the phosphor of formula I in particulate form with a first solution including a compound of formula II: Ax[MFy] to form a suspension and combining a second solution with the suspension, the second solution including a precursor including an element selected from the group consisting of calcium, strontium, magnesium, yittrium, barium, scandium, lanthanum, and combinations thereof. A population of particles having a core including a phosphor of formula I and a manganese-free composite coating disposed on the core, and a lighting apparatus (10) including the population of particles are also presented.

Abstract: The present disclosure relates to a composition of albumin microbubbles to which are bound one or more moieties that exhibit a binding preference for the albumin microbubbles relative to free, native HSA. Production of the albumin microbubble composition and use of the albumin microbubble composition in ultrasound mediated delivery of therapeutic or diagnostic agents is also discussed.

Abstract: Briefly, in one aspect, the present invention relates to processes for producing a stabilized Mn4+ doped phosphor in solid form and a composition containing such doped phosphor. Such process may include combining a) a solution comprising at least one substance selected from the group consisting of: K2HPO4, an aluminum phosphate, oxalic acid, phosphoric acid, a surfactant, a chelating agent, or a combination thereof, with b) a Mn4+ doped phosphor of formula I in solid form, where formula I may be: Ax [MFy]:Mn4+. The process can further include isolating the stabilized Mn4+ doped phosphor in solid form. In formula I, A may be Li, Na, K, Rb, Cs, or a combination thereof. In formula I, M may be Si, Ge, Sn, Ti, Zr, Al, Ga, In, Sc, Y, La, Nb, Ta, Bi, Gd, or a combination thereof. In formula I, x is the absolute value of the charge of the [MFy] ion and y is 5, 6 or 7.

Abstract: The present disclosure relates to a composition of albumin microbubbles to which are bound one or more moieties that exhibit a binding preference for the albumin microbubbles relative to free, native HSA. Production of the albumin microbubble composition and use of the albumin microbubble composition in ultrasound mediated delivery of therapeutic or diagnostic agents is also discussed.

Abstract: Syringe systems including barrels having lubricated portions and non-lubricated portions are provided. The non-lubricated portions may be configured to be loaded with injectable materials, such as embolic agents. The injectable materials may comprise polyvinyl alcohol. Also provided are methods of lubricating portions of barrels of syringe systems with lubricants including silicone or silicone-free lubricants.

Abstract: Coverings for syringe plunger tips, as well as syringes and syringe components including such coverings, are disclosed. A material of the covering may have at least one different material property than a material of the plunger tip. The coverings may provide a reduced coefficient of friction between the covering and a surface of the syringe relative to the coefficient of friction between the plunger tip and the syringe surface. The coverings may also isolate a substance loaded in the syringe from the plunger tip. Methods for manufacturing a syringe assembly including such coverings, as well as methods for isolating a substance in a syringe from a syringe component, are also disclosed.